Cardiac surgery in patients with human immunodeficiency virus infection: indications and results.
Ten patients with human immunodeficiency virus (HIV) infections underwent cardiac surgery using cardiopulmonary bypass. All were in Centers for Disease Control (CDC) group II. The cardiac involvement was either urgent or severely symptomatic in all cases. One patient died due to acquired immunodeficiency syndrome (AIDS) unrelated cause. No complications were encountered in this series. Eight of the nine survivors were available for follow-up. Three of these eight patients progressed to AIDS (CDC group IV) and subsequently died. Five patients are alive and in CDC group II. Prognosis of the HIV infection and the natural history of the cardiac disease are the two main elements to be considered whenever cardiac surgery is required.
Sousa Uva
M
M
Department of Cardiovascular Surgery, Hospital Broussais, Paris, France.
Jebara
V A
VA
Fabiani
J N
JN
Castel
S M
SM
Acar
C
C
Grare
P
P
Dib
J C
JC
Deloche
A
A
Carpentier
A
A
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000401:mortality; D000293:Adolescent; D000328:Adult; D001024:Aortic Valve Stenosis / Q000150:complications / Q000151:congenital* / Q000601:surgery*; D002315:Cardiopulmonary Bypass; D002648:Child; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000150:complications / Q000601:surgery*; D011379:Prognosis; D011475:Prosthesis Failure; D016459:Prosthesis-Related Infections / Q000601:surgery*